JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2015, Vol. 53 ›› Issue (9): 53-57.doi: 10.6040/j.issn.1671-7554.0.2015.296

Previous Articles     Next Articles

Over expression of lipin1 attenuates diabetic peripheral neuropathy in rats

XU Yi1, ZHUANG Xianghua1, LIU Yuantao1, SUN Aili1, LI Xiaobo1, JIANG Dongqing1, ZHANG Liang1, XU Min1, YAN Heng2, CHEN Shihong1   

  1. 1. Department of Endocrinology, Second Hospital of Shandong University, Jinan 250033, Shandong, China;
    2. Department of Anesthesiology, Second Hospital of Shandong University, Jinan 250033, Shandong, China
  • Received:2015-03-15 Online:2015-09-10 Published:2015-09-10
  • Contact: 陈诗鸿。E-mail:chenshihong26@163.com E-mail:chenshihong26@163.com

Abstract: Objective To investigate the effects of lipin1 on diabetic peripheral neuropathy in rats. Methods Type 2 diabetes mellitus was induced in male Wistar rats which were fed with high fatty and high sugar diet for 8 weeks, followed by streptozotocin (STZ) injection intraperitoneally. And then the models were randomly divided into Lipin1 high expression (LV-Lipin1) group and empty vector (LV-control) group. Another 12 age-matched non-diabetic rats served as controls. Rats in LV-Lipin1 group were transfected with lentiviral vector expressing rat lipin1; rats in LV-control group were transfected with lentiviral empty vector. After two months, fasting blood glucose, body weight and the motor nerve conduction velocity (MNCV) were measured. Histopathological changes of sciatic nerve were analyzed with light microscope and electron microscope; Lipin1 expression was evaluated with immunohistochemistry. Results Two months after diabetes was induced, expression of Lipin1 in sciatic nerves was significantly decreased in the LV-control group compared with control group. The nerve fiber diameter, nerve fiber area and nerve fiber density in LV-control group were also decreased compared with control group. All of the above changes were significantly attenuated in LV-Lipin1 group. Motor nerve conduction velocity (MNCV) of sciatic nerve in LV-Lipin-1 group was significantly improved compared with LV-control group (P<0.05). Conclusion Expression of Lipin1 in sciatic nerve decreases in diabetic peripheral neuropathy rats. Upregulation of Lipin1 expression significantly improves the MNCV and nerve pathological morphology.

Key words: Lipin1, Peripheral neuropathy, Diabetes, Lentivirus

CLC Number: 

  • R587.1
[1] Ko SH, Kwon HS, Yu JM, et al. Comparison of the efficacy and safety of tramadol/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathy[J]. Diabet Med, 2010, 27(9): 1033-1040.
[2] Péterfy M, Phan J, Xu P, et al. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin[J]. Nat Genet, 2001, 27(1): 121-124.
[3] Nadra K, de Preux Charles AS, Medard JJ, et al. Phosphatidic acid mediates demyelination in Lpin1 mutant mice[J]. Genes Dev, 2008, 22(12): 1647-1661.
[4] 尚画雨, 夏志, 张丹, 等. 8周游泳运动对2型糖尿病大鼠周围神经病变的影响[J]. 中国病理生理杂志, 2014, 30(4): 719-724. SHANG Huayu, XIA Zhi, ZHANG Dan, et al. Influence of 8-week swimming on peripheral neuropathy in type 2 diabetic rats[J]. Chinese Journal of Pathophysiology, 2014, 30(4): 719-724.
[5] Tesfaye S, Boulton AJM, Dyck PJ, et al. Diabetic neuropathies: update on definitions,diagnostic criteria, estimation of severity, and treatments[J]. Diabetes care, 2010, 33(10): 2285-2293.
[6] Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: where are we now and where to go?[J]. Diabetes Investig, 2011, 2(1): 18-32.
[7] 唐胜球, 江青艳, 杨楚芬, 等. Lipin家族研究进展[J]. 遗传, 2010, 32(10): 981-993. TANG Shengqiu, JIANG Qingyan, YANG Chufen, et al. Research and development of Lipin family[J]. Hereditas, 2010, 32(10): 981-993.
[8] Gowri PM, Sengupta S, Bertera S, et al. Lipin1 regulation by estrogen in uterus and liver: implications for diabetes and fertility[J]. Endocrinology, 2007, 148(8): 3685-3693.
[9] Mul JD, Nadra K, Jagalur NB. A hypomorphic mutation in Lipin1 induces progressively improving neuropathy and lipodystrophy in the rat[J]. J Biol Chem, 2011, 286(30): 26781-26793.
[10] Nadra K, de Preux Charles AS, Medard JJ, et al. Phosphatidic acid mediates demyelination in Lpin1 mutant mice[J]. Genes Devel, 2008, 22(12): 1647-1661.
[11] Verheijen MH, Chrast R, Burrola P, et al. Local regulation of fat metabolism in peripheral nerves[J]. Genes Dev, 2003, 17(19): 2450-2464.
[12] 王国凤, 徐宁, 尹冬, 等. 糖尿病周围神经病变的诊断和治疗新进展[J]. 中国全科医学, 2012, 15(15): 1661-1663. WANG Guofeng, XU Ning, YIN Dong, et al. Diagnosis and treatment progress of diabetic peripheral neuropathy[J]. Chinese General Practice, 2012,15(15): 1661-1663.
[13] Ling Q, Liu M, Wu MX, et al. Anti-allodynic and neuroprotective effects of koumine, a benth alkaloid, in a rat model of diabetic neuropathy[J]. Biol Pharm Bull, 2014, 37(5): 858-864.
[14] Reitman ML.The fat and thin of lipin[J]. Cell Metab, 2005, 1(1): 5-6.
[15] van Harmelenm V, Rydén M, Sjölin E, et al. A role of lipin in human obesity and insulin resistance: relation to adipocyte glucose transport and GLUT4 expression[J]. Lipid Res, 2007, 48(1): 201-206.
[16] Ueta K, Ishihara T, Matsumoto Y, et al. Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats[J]. Life Sci, 2005, 76: 2655-2668.
[17] 方萍, 黄佳佳, 侯瑞芳, 等. 严格血糖控制对糖尿病周围神经病变的影响[J]. 中国糖尿病杂志, 2012, 20(1): 31-35. FANG Ping, HUANG Jiajia, HOU Ruifang, et al. Effect of intensive blood glucose control on the progression of diabetic peripheral neuropathy (DPN)[J]. Chinese Journal of Diabetes, 2012, 20(1): 31-35.
[1] ZHANG Liang, XU Min, ZHUANG Xianghua, LOU Fuchen, LOU Nengjun, LÜ Li, GUO Wenjuan, ZHENG Fengjie, CHEN Shihong. An investigation of endoplasmic reticulum stress and apoptosis in diabetic peripheral neuropathy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(8): 13-17.
[2] SU Ping, YANG Yachao, YANG Yang, JI Jiadong, DAYIMU Alimu, LI Min, XUE Fuzhong, LIU Yanxun. Prediction models on the onset risks of type 2 diabetes among the health management population [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(6): 82-86.
[3] ZHANG Zhentang, YANG Yang, HAN Fujun, CHEN Xianghua, JI Xiaokang, WANG Yongchao, WANG Shukang, SUN Yuanying, LI Min, CHEN Yafei, WANG Li, XUE Fuzhong, LIU Yanxun. A prediction model of 5-year CVD risks for type 2 diabetic patients: a prospective cohort study among Chinese community population [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(6): 108-113.
[4] LI Shuai, WANG Yalin, SUN Zhongwen, ZHU Meijia. Expression changes and mechanism of Nod-like receptor protein 3 inflammasome in the cerebral microvascular endothelial cells in type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 6-11.
[5] XIE Haibin, WU Qunzheng, LIU Shaozhuang, HUANG Xin, CHENG Yugang, HU Sanyuan, ZHANG Guangyong. Role of mitochondria-associated membranes in the improvement of insulin sensitivity in diabetic rats after sleeve gastrectomy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 36-40.
[6] YANG Yang, ZHANG Guang, ZHANG Chengqi, SONG Xinhong, XUE Fuzhong, WANG Ping, WANG Li, LIU Yanxun. A prediction model for type 2 diabetes risks: a cohort study based on health examination [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(9): 69-72.
[7] PENG Li, QIANG Ye, ZHAO Huichen, CHEN Shihong, YAO Weidong, LIU Yuantao. Clinical studies on type 2 diabetic patients treated with sitagliptin [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 60-63.
[8] LIN Dong, GUAN Qingbo. Association of serum testosterone level and non-alcoholic fatty liver disease in male patients with T2DM [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 33-37.
[9] SHI Rui, SUN Pei, WANG Lulu, DING Lin, XIA Jin, WANG Yan, PANG Shuguang. Vitamin D and mecobalamin combined with mouse nerve growth factor for diabetic peripheral neuropathy: a clinical observation [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(4): 64-67.
[10] YANG Junlin, WANG Qinghua, WANG Zengjin, ZHAO Xiulan. Elevated proteasomal activities in rats peripheral nervous system exposed to 1-Bromopropane [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(4): 78-83.
[11] Muhadasi TUERXUNYIMING, Patamu MOHEMAITI, Tuolanguli MAIMAITIKUERBAN. Association of CDKAL1 rs10946398 C/A polymorphism with type 2 diabetes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(2): 75-85.
[12] YU Ning, GAO Yanyan, XIAN Yuxin, NIU Jiapeng, LI Li, WANG Jing, CAO Caixia. Effect of exenatide on serum chemerin level and liver fat contents in type 2 diabetes mellitus combined with non-alcoholic fatty liver disease patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(11): 51-55.
[13] YU Lu, LIU Qiang. Introvoxel incoherent motion MR imaging for the assessment of renal function of diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(11): 68-71.
[14] ZHAO Huichen, CHAI Jiachao, ZHANG Liang, YUAN Mingzhen, PENG Li, LIU Yuantao. Changes of hydrogen sulfide concentrations and synthetase expressions in the corpus cavernosum of diabetic rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(10): 25-28.
[15] CHEN Zhixin, WANG Ying, CAO Xinran, HEI Naihao, LI Junlong, DONG Bo, GUAN Guangju. Evaluation of the protective effect of AVE0991 on streptozotocin-induced diabetic nephropathy rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(10): 29-33.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!